Cardiology
Pulmonic Valve Stenosis
~10 min read9 sections
Contents (9)
Pulmonic valve stenosis (PS) is characterized by obstruction to right ventricular (RV) outflow across a narrowed pulmonic valve orifice, resulting in elevated RV systolic pressure and eventual RV hypertrophy. It is the most common congenital heart lesion in isolation, accounting for approximately 7-10% of congenital heart disease. PS occurs across a wide spectrum of severity from mild stenosis with normal exercise tolerance to severe obstruction requiring intervention. The condition may be isolated or occur as part of complex lesions (Tetralogy of Fallot, carcinoid syndrome, rheumatic disease). Clinical significance depends on the degree of obstruction; mild PS is often benign and nonprogressive, while severe PS necessitates intervention to prevent RV decompensation and sudden cardiac death.
- RV Afterload Elevation and Hypertrophy: Obstruction at the pulmonic valve narrows the orifice area, increasing resistance to RV ejection. This increased afterload triggers concentric RV hypertrophy as cardiomyocytes increase contractile mass. The thickened RV wall becomes stiff, impairing diastolic compliance and resulting in diastolic dysfunction. Over time, chronic pressure overload may lead to RV dilatation and systolic dysfunction, particularly in severe untreated cases.
- Pressure Gradient Development: The stenotic valve creates a systolic pressure gradient between the RV and pulmonary artery. This gradient is directly proportional to the stenosis severity and inversely related to valve area. Hemodynamic assessment reveals elevated RV systolic pressure with relatively low pulmonary artery pressure, distinguishing PS from pulmonary hypertension. The gradient drives compensatory mechanisms including increased RV contractility and eventual myocardial fatigue.
- Right Atrial Pressure Elevation: Severe PS impairs RV filling due to reduced compliance and prolonged isovolumetric relaxation. This causes retrograde transmission of elevated pressure to the right atrium and systemic venous circulation, leading to hepatomegaly, elevated jugular venous pressure (JVP), and potential right-to-left shunting through patent foramen ovale (PFO) or atrial septal defect (ASD), causing cyanosis (particularly with coexistent shunts).
- Congenital Valve Abnormalities (most common, ~90% of cases): Abnormal valve development leads to valvular PS characterized by stenosis at the valve leaflet level. Dysplastic, thickened, or immobile leaflets with commissural fusion are typical histopathologic findings. This is frequently associated with noonan syndrome (PTPN11 mutations), which presents with distinctive facies, short stature, and cardiac involvement (50-80% have cardiovascular abnormalities, often PS).
- Supravalvular and Subvalvular Obstruction: Supravalvular PS results from narrowing of the pulmonary artery and its branches (seen in Williams syndrome, Alagille syndrome, rubella embryopathy). Subvalvular PS involves infundibular narrowing from muscular RV outflow tract hypertrophy, often progressing over time as the hypertrophied muscle increases obstruction.
- Acquired PS: Carcinoid syndrome causes thickened, retracted pulmonic valve leaflets from serotonin-induced fibrosis (same mechanism as tricuspid involvement). Rheumatic heart disease rarely affects the pulmonic valve in isolation. Endocarditis, systemic sclerosis, and previous radiation therapy represent uncommon acquired causes.
- Associated Genetic Syndromes: Noonan syndrome (most common syndromic association), Williams syndrome, Alagille syndrome, Marfan syndrome, Ehlers-Danlos syndrome.
- Cardinal Symptom - Dyspnea on Exertion: Dyspnea typically appears with moderate-to-severe stenosis as RV afterload limitation restricts cardiac output during increased metabolic demand. Severe PS may present with presyncope or syncope due to fixed cardiac output inability to increase with exertion. Fatigue and exercise intolerance are common complaints.
- Physical Examination - Cyanosis: Cyanosis appears when severe PS coexists with right-to-left shunting through a PFO or ASD. The shunt develops because elevated RA pressure exceeds LA pressure, enabling desaturated venous blood to bypass pulmonary circulation. Cyanosis is notably absent in isolated PS without a shunt.
- Physical Examination - Prominent Right Ventricular Heave: Palpation reveals a sustained, forceful parasternal impulse reflecting RV hypertrophy and increased contractility. The heave is best appreciated with patient in left lateral decubitus position. A palpable RV impulse may also be present at the epigastrium or right sternal border.
- Cardiac Auscultation - Ejection Systolic Murmur: A crescendo-decrescendo systolic murmur at the left upper sternal border (2nd-3rd intercostal space) radiates toward the left shoulder. The murmur's timing reflects RV ejection duration; severe PS prolongs ejection, delaying murmur peak. The murmur increases with inspiration (Carvallo sign) as increased RV return augments flow. A systolic ejection click precedes the murmur in valvular PS (click marks valve opening); click is absent in subvalvular PS (no valve motion).
- Additional Cardiac Findings: A dilated, pulsatile liver may be palpable if RV dysfunction elevates RA pressure. Atrial fibrillation can develop with chronic RA pressure elevation. Splitting of the second heart sound (S2) is normal or may show persistent splitting if RV ejection is prolonged.
- Asymptomatic Presentation: Mild PS is often discovered incidentally on cardiac auscultation in asymptomatic individuals during routine examination or screening.
- Electrocardiography (ECG): Shows right axis deviation and RV hypertrophy (tall R waves in V1-V2, deep S waves in V5-V6) proportional to stenosis severity. Mild PS may show normal ECG. Severe PS exhibits prominent RV strain pattern with T-wave inversion in right precordial leads (V1-V3). Right atrial enlargement appears as peaked P waves in leads II and V1 (P pulmonale). Atrial fibrillation may be evident in advanced disease.
- Chest Radiography: Demonstrates RV enlargement with convex left heart border and elevated apex. Prominent pulmonary artery is visible at the hilum in mild-to-moderate cases. Pulmonary vascular markings are typically normal (distinguishing PS from pulmonary hypertension with pulmonary congestion). Cardiac silhouette size correlates with stenosis severity.
- Transthoracic Echocardiography (gold standard diagnostic test): Provides definitive diagnosis and severity stratification via:
- Two-dimensional imaging: Visualizes thickened, domed valve leaflets with restricted systolic opening in valvular PS; muscular RV outflow tract narrowing in subvalvular PS; normal valve appearance with pulmonary artery narrowing in supravalvular PS.
- Doppler echocardiography: Measures peak systolic pressure gradient across the pulmonic valve using modified Bernoulli equation (gradient = 4V², where V is peak jet velocity). Peak instantaneous gradient is standard measurement.
- RV and RA dimensions: Increased RV dimension reflects chronic afterload elevation; RA enlargement indicates elevated RA pressure.
- Diagnostic Criteria by Severity:
- Mild PS: Peak gradient <35 mmHg, normal RV function, asymptomatic
- Moderate PS: Peak gradient 35-80 mmHg, mild RV hypertrophy
- Severe PS: Peak gradient >80 mmHg, RV hypertrophy with diastolic dysfunction, RV cavity enlargement, elevated RA pressure
- Cardiac Catheterization: Reserved for hemodynamic assessment when noninvasive data are inconclusive, or for therapeutic intervention. Reveals elevated RV systolic pressure with normal pulmonary artery pressure (gradient >50 mmHg indicates intervention). Angiography defines valve morphology and pulmonary artery anatomy, particularly in supravalvular disease.
- Cardiac Magnetic Resonance (CMR): Excellent for assessing RV volume, mass, and function; particularly valuable for detecting associated anomalies or planning surgical repair. Less flow-dependent than echocardiography for severely abnormal flows.
- Exercise Stress Testing: May provoke symptoms in moderate stenosis and objectively assesses exercise tolerance. Demonstrates lack of appropriate BP rise in severe PS (fixed cardiac output).
- Observation and Conservative Management (Mild PS): Asymptomatic patients with peak gradient <35-40 mmHg require only clinical and echocardiographic surveillance every 2-3 years. Most patients with mild, stable PS remain stable without progression. Annual evaluation is appropriate if mild PS but with borderline hemodynamics. Prophylactic antibiotic endocarditis prophylaxis is not recommended for isolated PS (low risk). Normal activity and exercise are permitted without restriction.
- Intervention - Balloon Pulmonic Valvuloplasty (First-line for hemodynamically significant PS): Percutaneous catheter-based intervention is preferred therapy when peak gradient exceeds 50 mmHg or moderate gradient (35-50 mmHg) with RV dilation or symptomatic status. Under fluoroscopic guidance, an inflated balloon traverses the stenotic orifice, fracturing commissural fusions and expanding valve area. Success rates exceed 90% with gradient reduction >50%. Major advantage is avoidance of surgery with shorter recovery. Complications (10%) include pulmonary regurgitation, balloon rupture, ventricular perforation. Restenosis occurs in ~10% over 5-10 years, necessitating repeat procedures in minority.
- Surgical Intervention - Pulmonic Valve Replacement/Repair: Indicated when valvuloplasty fails, recurrent stenosis develops, or dysplastic valve anatomy precludes successful balloon dilation. Pulmonary valve commissurotomy (surgical splitting of fused commissures) is performed for simple valvular disease. Valve replacement with bioprosthetic or mechanical prosthesis is necessary for irreversible valve damage. Subvalvular obstruction requires infundibular myectomy and sometimes patch widening of the outflow tract. Supravalvular stenosis may require pulmonary artery patch angioplasty. Surgical mortality is low (<2%) in uncomplicated cases.
- Monitoring and Follow-up: Regular clinical assessment every 1-2 years with echocardiography. Hemodynamics should be reassessed if symptoms develop. Pregnant women with severe PS may decompensate (increased circulating volume and decreased systemic vascular resistance diminish compensatory mechanisms) and require close monitoring. Women with mild-moderate uncomplicated PS tolerate pregnancy well.
- Endocarditis Prophylaxis: Antibiotic prophylaxis is not routinely recommended for isolated PS. Prophylaxis is considered for cyanotic lesions with shunts, complex disease, or prosthetic valves.
- Infective Endocarditis: Risk is relatively low in isolated PS but increases with complex lesions or prosthetic replacement. Presents with fever, new/changing murmur, positive blood cultures, and septic emboli. Management includes prolonged IV antibiotics (typically 4-6 weeks) and consideration of surgical valve replacement if large vegetations, paravalvular abscess, or hemodynamic instability develop.
- Right Ventricular Dysfunction and Heart Failure: Chronic severe afterload leads to progressive RV hypertrophy, eventual dilation, and systolic dysfunction. RV failure manifests as hepatomegaly, elevated JVP, edema, and ascites. Treated with diuretics, ACE inhibitors, and beta-blockers; however, definitive therapy requires relieving obstruction via valvuloplasty or surgery.
- Atrial Fibrillation: Develops due to chronic RA pressure elevation and RA dilation. AF increases thromboembolic risk and may precipitate hemodynamic deterioration. Anticoagulation is indicated; rate control with beta-blockers or calcium channel blockers is essential. Ablation may be considered for refractory AF.
- Sudden Cardiac Death: Although uncommon, occurs in severe untreated PS, particularly with exertion. Mechanism involves RV ischemia (increased wall stress reduces coronary perfusion pressure), arrhythmias, or acute RV failure. Prevention requires timely intervention to reduce pressure gradient.
- Cyanosis with Right-to-Left Shunting: Develops when severe PS coexists with ASD or PFO, allowing RA pressure to exceed LA pressure. Management focuses on relieving PS obstruction; shunt closure alone without addressing stenosis is insufficient. Phlebotomy for elevated hemoglobin (>65%) may improve rheologic blood flow and reduce thromboembolic risk.
- Prosthetic Valve Complications (if replaced): Structural valve degeneration (bioprosthetic valves degenerate over 10-15 years), mechanical valve thrombosis, prosthetic endocarditis, pannus ingrowth. Mechanical valves require lifelong anticoagulation; bioprosthetic valves eventually necessitate reoperation.
Natural History and Outcomes: Prognosis is excellent for mild PS, with most asymptomatic patients remaining stable over decades without hemodynamic progression. Approximately 80% of patients with mild stenosis never require intervention. Progressive stenosis is uncommon but can occur in dysplastic valves or after valvuloplasty with restenosis. Symptomatic severe PS has poor prognosis without intervention; sudden death risk increases with exertion, and heart failure develops within years.
Post-Intervention Outcomes: Balloon valvuloplasty achieves 85-95% success rates with excellent long-term outcomes; 70-80% of patients remain free of restenosis at 10 years. Surgical commissurotomy has similar success with durability. Valve replacement (bioprosthetic or mechanical) provides durable relief but introduces prosthetic complications and requires long-term monitoring. Survival following successful intervention approaches that of the general population.
Prognostic Factors: Peak gradient severity is strongest predictor of progression and need for intervention. RV function (preserved vs. depressed) predicts tolerance of stenosis. Age at intervention influences long-term outcomes; pediatric patients undergoing balloon valvuloplasty have excellent prognosis with normal lifespan expectancy. Associated complex congenital lesions and syndromic diagnoses may worsen prognosis.
- Most Important Fact: Balloon pulmonic valvuloplasty is the first-line intervention for hemodynamically significant PS, with >90% success and low complication rates, replacing surgery in most cases. Intervention is indicated when peak gradient exceeds 50 mmHg or moderate gradient (35-50 mmHg) with symptoms or RV dilation.
- Classic Board Buzzword: "Noonan syndrome with pulmonic stenosis" — always think of Noonan when you see PS in a patient with characteristic facial features (hypertelorism, ptosis, micrognathia), short stature, or family history of congenital heart disease.
- Auscultatory Pearl: Ejection click absent in subvalvular PS but present in valvular PS — the click marks valve opening; absence indicates muscular obstruction rather than valve stenosis. Inspiratory increase in murmur intensity (Carvallo sign) confirms right-sided origin.
- Common Clinical Trap: Do not confuse mild PS with innocent systolic murmur. Key distinguishing features: PS murmur is ejection-type (crescendo-decrescendo), occurs with ejection click, increases with inspiration, and appears at left upper sternal border. Innocent murmurs lack ejection click and have no associated cardiac findings.
- Another Trap: Cyanosis is NOT typical of isolated PS without a shunt. If cyanosis is present, search for coexisting ASD, PFO, or complex lesion. Cyanosis indicates right-to-left shunting.
- Mnemonic for PS Severity and Intervention (PEAK GRADIENT):
- <35 mmHg: Mild, observe
- 35-50 mmHg: Moderate, monitor; intervene if symptomatic
- >50 mmHg: Severe, intervene
- Endocarditis Prophylaxis Rule: No prophylaxis for isolated PS (low